Ad is loading...
GLCUX
Price
$36.40
Change
-$0.83 (-2.23%)
Updated
Nov 15 closing price
RGAHX
Price
$78.97
Change
-$1.33 (-1.66%)
Updated
Nov 15 closing price
Ad is loading...

GLCUX vs RGAHX

Header iconGLCUX vs RGAHX Comparison
Open Charts GLCUX vs RGAHXBanner chart's image
Goldman Sachs Large Cap Gr Insghts R6
Price$36.40
Change-$0.83 (-2.23%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R5E
Price$78.97
Change-$1.33 (-1.66%)
VolumeN/A
CapitalizationN/A
GLCUX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GLCUX vs. RGAHX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLCUX is a Buy and RGAHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 298B vs. GLCUX (1.37B). RGAHX pays higher dividends than GLCUX: RGAHX (0.64) vs GLCUX (0.08). GLCUX was incepted earlier than RGAHX: GLCUX (9 years) vs RGAHX (9 years). GLCUX is a more actively managed with annual turnover of: 206.00 vs. RGAHX (31.00). RGAHX has a lower initial minimum investment than GLCUX: RGAHX (250) vs GLCUX (5000000). GLCUX (29.53) and RGAHX (28.11) have marching annual gain over last year. RGAHX return over 5 years is better than : 53.44 vs. GLCUX (9.96).
GLCUXRGAHXGLCUX / RGAHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years9 years-
Gain YTD31.31326.656117%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.37B298B0%
Annual Yield % from dividends0.080.6413%
Returns for 1 year29.5328.11105%
Returns for 3 years-29.47-4.25693%
Returns for 5 years9.9653.4419%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USNA40.340.90
+2.28%
USANA Health Sciences
BGNE189.23-4.06
-2.10%
BeiGene Ltd
HI32.77-0.93
-2.76%
Hillenbrand
BENF1.20-0.05
-4.00%
Beneficient
ACRV6.96-0.96
-12.12%
Acrivon Therapeutics